MEMPHIS, Tenn., Aug. 6, 2019 /PRNewswire/ -- West Cancer Center is proud to announce the opening of its Pathology Histology Laboratory. The team is led by Dr. David Robins, an M.D. Anderson trained pathologist with 30 years of experience in pathology. Biopsy samples from Margaret West Comprehensive Breast Center, West Cancer Center Int

SAN ANTONIO, Texas, Aug. 6, 2019 /PRNewswire/ -- CeloNova BioSciences, Inc. (CeloNova), a global medical device company and manufacturer of the proprietary Polyzene

ALPHARETTA, Ga., Aug. 6, 2019 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) today reported second quarter 2019 results and revised its full-year 2019 outlook.

MONTREAL and CHARLOTTE, N.C., Aug. 6, 2019 /PRNewswire/ -- Milestone Pharmaceuticals Inc. (Nasdaq: MIST), a Phase 3 clinical-stage biopharmaceutical company dedicated to developing and commercializing etripamil for the treatment of cardiovascular indications, today announced that it will host a mid-year update conference call on

TARRYTOWN, N.Y., Aug. 6, 2019 /PRNewswire/ ---- Second quarter 2019 revenues increased 20% to $1.93 billion versus second quarter 2018EYLEA® U.S. net sales increased 17% to $1.16 billion versus second quarter 2018 Dupixent® global net sa

MINNEAPOLIS, Aug. 6, 2019 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) announced that its Board of Directors has decided to pay a dividend of $0.32 per share for the quarter ended June 30, 2019. The quarterly dividend will be payable August 30, 2019 to all common share

MINNEAPOLIS, Aug. 6, 2019 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ:TECH) today reported its financial results for the fourth quarter ended June 30, 2019.Fourth Quarter FY2019 SnapshotFourth quarter organic growth of 7% (6% reported) to $191.7 million. Full year or

CONCORD, Calif., Aug. 6, 2019 /PRNewswire/ -- Today, Nonstop Administration and Insurance Services, Inc. (Nonstop), a nontraditional health insurance broker committed to reducing barriers to quality, affordable healthcare through first dollar coverage, is announcing a new alignment of like-minded organizations committed to helping California

SILVER SPRING, Md. and RESEARCH TRIANGLE PARK, N.C., Aug. 6, 2019 /PRNewswire/ -- United Therapeutics Corporation (Nasdaq: UTHR) announced today that Martine Rothblatt, Ph.D., Chairman and Chief Executive Officer of United Therapeutics, will provide an overview and update on the company's business at the 201

LOS ANGELES, Aug. 6, 2019 /PRNewswire/ -- Jessica Billingsley is determined not to be the only CEO of a NASDAQ-traded cannabis technology company for long. Since taking the helm of Akerna Corp. in June, Billingsley has been on dual missions: Expand the $72 billion company and encourage tech and cannabis compani